Improved outcomes following addition of bedaquiline and clofazimine to a treatment regimen for multidrug-resistant tuberculosis

OBJECTIVE: To investigate if the addition of bedaquiline and clofazimine to a treatment regimen for multidrug-resistant tuberculosis (MDR-TB) could improve patient outcomes. METHODS: A prospective, randomized, controlled study was conducted in patients with MDR-TB. Treatment was for 18 months. Patie...

Descripción completa

Detalles Bibliográficos
Autores principales: Yao, Ge, Zhu, Muxin, Nie, Qi, Chen, Nanshan, Tu, Shengjin, Zhou, Yong, Xiao, Fan, Liu, Yuan, Li, Xi, Chen, Hua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Prospective Clinical Research Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9893081/
https://www.ncbi.nlm.nih.gov/pubmed/36719280
http://dx.doi.org/10.1177/03000605221148416

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9893081/
https://www.ncbi.nlm.nih.gov/pubmed/36719280
http://dx.doi.org/10.1177/03000605221148416

Ejemplares similares